eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 08/07/2011
PIL Calcium Resonium 99.934% w/w Powder for Oral/Rectal Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 08/03/2011 and displayed until 08/07/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 18/10/2010 and displayed until 08/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 18/08/2010 and displayed until 18/10/2010
Reasons for adding or updating:
  • Change to packaging
Updated on 03/06/2008 and displayed until 18/08/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 27/07/2006 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 13/04/2005 and displayed until 27/07/2006
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 22/10/2004 and displayed until 13/04/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   calcium polystyrene sulphonate